Featured Stories

View all →
 Obeda: How Dr. Reddy's Entered India's Semaglutide Race
Healthcare

Obeda: How Dr. Reddy's Entered India's Semaglutide Race

As India's pharmaceutical industry enters a new era of competition around one of the world's most closely watched diabetes and weight-management molecules, Dr. Reddy's Laboratories has placed its bet on affordability, scientific capability and a distinctive brand identity. But the journey of Obeda also demonstrates how quickly a promising healthcare launch can encounter the challenges of manufacturing and market confidence.

10 min read Healthcare